Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow Quality Index
Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Quality Index of 0.50x as of September 2025. Operating cash flow of ₩11.28 Billion is below net income of ₩22.41 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Il Dong Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Il Dong Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2018)
Historical Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Il Dong Pharmaceutical Co Ltd (249420) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd (2016–2018)
Year-by-year earnings quality comparison for Il Dong Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market value of Il Dong Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 5.24x | ₩66.65 Billion | ₩12.72 Billion | ▲ +41.0% |
| 2017 | 3.72x | ₩73.72 Billion | ₩19.84 Billion | ▲ +1.7% |
| 2016 | 3.66x | ₩45.98 Billion | ₩12.58 Billion | — |